Skip to content

Effect of Banxia Xiexin Decoction on plasma GLP-1 level in newly diagnosed type 2 diabetic patients

Effect of Banxia Xiexin Decoction on plasma GLP-1 level in newly diagnosed type 2 diabetic patients

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100042932
Enrollment
Unknown
Registered
2021-01-31
Start date
2021-02-22
Completion date
Unknown
Last updated
2021-05-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes

Interventions

Sponsors

Guang'anmen Hospital, China Academy of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) They were in accordance with the diagnostic criteria of type 2 diabetes in western medicine; (2) According to the diagnostic criteria of diabetes in TCM; (3) The age is 18-70 years old, regardless of gender; (4) According to the control diet, stable exercise for more than 2 weeks; (5) Informed consent has been signed.

Exclusion criteria

Exclusion criteria: (1) Pregnant and lactating women and patients with gestational diabetes mellitus; (2) Severe primary diseases such as heart, cerebrovascular, liver, kidney and hematopoietic system were found; (3) Psychopath; (4) Severe complications of diabetes mellitus; (5) Allergic constitution and multiple drug allergy. (6) Those who have poor compliance.

Design outcomes

Primary

MeasureTime frame
GLP-1;

Secondary

MeasureTime frame
GIP;PYY;FGF21;weight;fasting blood glucose;2h postprandial blood glucose;glycosylated hemoglobin;HOMA IR;Glucagon;TCM symptoms;

Countries

China

Contacts

Public ContactNi Qing

Guang'anmen Hospital, China Academy of Chinese Medicine

niqing669@163.com+86 13701253942

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026